Wearable Medical Device Market To Show $27 Million Revenue By 2023

  • The pain management segment of the $30 billion1 wearable medical device industry can offer investors an enticing opportunity.
  • Undiscovered companies selling for pennies a share can sometimes see strong momentum once their medical devices receive FDA approval.
  • Companies like the one we are discussing in this article, are developing new “wearable tech” devices for pain management, based on scientifically-validated2 heat therapy, that pro athletes such as Superbowl champion Deion Sanders say are “absolute gamechangers.”3

With the broader market losing steam and seeing increased volatility in recent months, some investors are zeroing in on specific micro niches once again in their search for potential profits.

One of the most lucrative niches has proven to be wearable medical device stocks – and in particular, shares of companies developing innovative wearable devices for pain management.

Small startup companies, such as the one we are discussing,  have begun designing new, low-cost, state-of-the-art wearable products aimed at treating and even preventing sports injuries and age-related joint and muscle pain.

Modest Investments, Potential Upside

Why such a narrow niche?  One reason is that medical device stocks in general can sometimes be off the charts. 

Companies such as the one we are discussing are often founded by entrepreneurs suffering from a particular ailment, such as lower back pain, and who then go in search of a personal solution to their problems. 

These are sometimes tiny, undiscovered enterprises that initially have just a single product to offer.  As a result, investors can often pick up thousands of shares for very modest amounts.

Yet once the pain management invention is patented and receives clearance from the U.S. Food and Drug Administration (FDA) as an approved wearable medical device, the once-tiny company can become a prime buyout candidate for Big Pharma. 

Former Canadian Pro Football Player Aims to Revolutionize the Prevention and Treatment of Chronic Pain

That’s why some investors are taking a close look at the new innovative company we are discussing and its development of new “wearable tech” pain relief products. 

The company was founded by a former professional football player whose career was cut short due to a severe ankle injury. This individual went on to become a registered inventor and entrepreneur who moved to China to learn about advanced manufacturing of medical devices. 

This entrepreneur quickly saw that the market for “wearable health tech” was exploding – yet the industry was hopelessly antiquated.  Suffering himself from chronic lower back pain likely from his pro football career, he knew that his treatment options were limited.

A Hungry Market and Obsolete Products

The few companies operating in the space concentrated on delivering cooling rather than heating modalities, despite the scientific evidence that shows the value of thermal applications for preventing and treating painful injuries.4

What’s more, designs had changed little in 50 years, with bulky batteries the norm, little concern for ergonomics and virtually no attempt to create products that could be worn during activity.

In addition, the few products that did exist were outrageously expensive.

As a result, this individual turned his attention to adapting the advanced carbon fiber heating technologies he developed with G-Tech Apparel for the rapidly expanding pain management market.

80% of Adults Experience Lower Back Pain

According to the National Institute of Neurological Disorders and Stroke, fully 80%5 of all adults experience lower back pain at some stage in their lives.  In fact, low back pain, after the common cold, is the most widespread ailment in human beings and the second most common reason for visiting the doctor.6

At any given period, at least 65 million Americans report suffering from a recent episode of lower back pain and 16 million suffer from Chronic Lower Back Pain (CLBP), defined as pain that persists for 12 weeks or longer.7

The causes are many and can include past injuries, disease, muscle strain, or stresses on different structures of the spine.

The costs associated with back pain are enormous – with an estimated 83 million days of work lost every year due to back pain.8

In western countries, the societal costs for back pain are estimated to be 1% to 2%[5] of the Gross National Product – which in the U.S. would be between $216 and $432 billion9 annually.

What’s more, for individuals lower back pain can lead to other, even more serious health problems due to prolonged inactivity – including obesity, diabetes and heart disease.

For that reason, the market for effective, especially non-drug treatments is exploding.

One recent analysis found that the market for treatments of Chronic Lower Back Pain worldwide is expected to soar to $9.3 billion by 2026.10

As a result, the attraction of this companies’ wearable health tech products, such as Warmup Series 1, is obvious.

Building a Wearable Back Pain Device That Provides Constant Soothing Relief

The company’s initial product is a wearable back compression and heating device originally designed to help professional athletes.

Its sleek, ergonomic design provides waves of constant soothing relief right in those sensitive areas of the lower back that other products rarely even touch.

What’s more, the product is so light and flexible it can be worn by athletes and active adults even when engaged in strenuous activities, including playing sports.

It’s perfect for anyone suffering from lower back pain, including golfers, weekend tennis players, and seniors.

Endorsed by Athletic Champions and Weekend Warriors Alike

As a result, this product has been endorsed by such professional athletes as the legendary dual-sport superstar Deion Sanders, a two-time Superbowl champion11 and World Series player.12

“This product has been an absolute gamechanger for me,” Sanders announced recently.  “While I was the best dual-sport athlete to ever play, my back has felt the effects for years.  The device is effective, easy-to-use and my best friend when my back pain flares up.”13

Right now, investors can pick up all the shares they want of the business we’re talking about for less than $1.00 per share.

And as with many other small companies marketing pain management devices, the company is flying far below radar for Wall Street analysts.

You can expect news to begin flowing at any time now, so getting in early keeps you in front of the crowds.

For the name of this exciting opportunity, enter your email address to download the latest investor publication and receive future news and updates.

[optin-monster slug="fohet3jujzdvhvyklzph"]

2“Superficial heat and spinal manipulation therapy are the most strongly supported evidence-based therapies. Nonsteroidal anti-inflammatory medications and skeletal muscle relaxants have benefit in the initial management of low back pain; however, both have considerable side effects that must be considered.” 
Ryan C. Petering, MD* and Charles Webb, DO, “Treatment Options for Low Back Pain in Athletes,” Sports Health. 2011 Nov; 3(6): 550–555. See online at:
6Furlan AD, Imamura M, Dryden T, Irvin E. Massage for low back pain: an updated systematic review within the framework of the Cochrane Back Review Group. Spine (Phila Pa 1976) 2009;34(16):1669–84.  Cited by Morteza Dehghan1 and Farinaz Farahbod, “The Efficacy of Thermotherapy and Cryotherapy on Pain Relief in Patients with Acute Low Back Pain, A Clinical Trial Study.”

Legal Notice: This website is owned and hosted by Market Tactic Media Ltd. Articles appearing on this website should be considered paid advertisements. Market Tactic Media Ltd. and its owners, managers, employees, and assigns (collectively “the Website Host”) is often paid by marketing companies to host websites on which articles profiling public companies are published. The articles on this website are not, and should not be construed to be, offers to sell or solicitations of an offer to buy any security. Neither the articles on this website nor the Website Host purport to provide a complete analysis of any company or its financial position. The Website Host is not, and does not purport to be, a broker-dealer or registered investment adviser. The articles on this website are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the profiled company’s SEC and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk.